Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors

MAA validation follows acceptance by the U.S. Food and Drug Administration (FDA) of the New Drug Application (NDA) for ...